AIM2 and pachyonychia congenita: This receptor mediates the release of pro-inflammatory and pro-fibrotic factors involved in PC-associated lung fibrosis, suggesting that AIM2 is an attractive molecular target that could help to early identify PC patients who are more likely to develop lung fibrosis and improve screening strategies.